Dogru GD, Tugcu AO, Dursun CU. Enhancing diagnostic frameworks in pancreatic cancer imaging: A critical appraisal. World J Radiol 2025; 17(3): 104818 [DOI: 10.4329/wjr.v17.i3.104818]
Corresponding Author of This Article
Galip Dogukan Dogru, MD, Department of Radiation Oncology, Gulhane Training and Research Hospital, General Dr. Tevfik Sağlam Street No. 1 Etlik, Ankara 06010, Türkiye. dogukandogru.95@gmail.com
Research Domain of This Article
Oncology
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Radiol. Mar 28, 2025; 17(3): 104818 Published online Mar 28, 2025. doi: 10.4329/wjr.v17.i3.104818
Enhancing diagnostic frameworks in pancreatic cancer imaging: A critical appraisal
Galip Dogukan Dogru, Ahmet Oguz Tugcu, Cemal Ugur Dursun
Galip Dogukan Dogru, Ahmet Oguz Tugcu, Department of Radiation Oncology, Gulhane Training and Research Hospital, Ankara 06010, Türkiye
Cemal Ugur Dursun, Department of Radiation Oncology, Kartal Dr. Lutfi Kirdar City Hospital, İstanbul 34865, Türkiye
Author contributions: All authors contributed to this letter to the editor; Dogru GD conceptualized the letter, drafted the manuscript, and approved the final version for publication; Tugcu AO contributed to the writing process, critically revised the content, and approved the final version; Dursun CU reviewed the relevant literature, supported manuscript preparation, and approved the submitted version; all authors have read and approved the final version of this letter.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Galip Dogukan Dogru, MD, Department of Radiation Oncology, Gulhane Training and Research Hospital, General Dr. Tevfik Sağlam Street No. 1 Etlik, Ankara 06010, Türkiye. dogukandogru.95@gmail.com
Received: January 7, 2025 Revised: March 4, 2025 Accepted: March 20, 2025 Published online: March 28, 2025 Processing time: 79 Days and 14.9 Hours
Core Tip
Core Tip: Luo et al's study highlights the potential of imaging-pathology correlations in pancreatic cancer diagnosis. However, integrating advanced imaging techniques like magnetic resonance cholangiopancreatography and positron emission tomography/computed tomography could significantly enhance diagnostic precision and provide valuable metabolic and anatomical insights. The inclusion of radiomics-based analyses offers an opportunity to extract quantitative imaging features, improving risk stratification and prognostication. Adopting longitudinal study designs could further elucidate the evolution of imaging features over time, aiding early detection and therapy planning. These enhancements align with trends in precision medicine, paving the way for more comprehensive and clinically impactful research in pancreatic cancer imaging.
